Google
EXOZ — EXOZYMES, INC. (Healthcare >> Biotechnology)
EXOZ FAQ
What is EXOZ's ROE?
EXOZYMES, INC. reports a Return on Equity (ROE) of -632.98%.
What is EXOZ's dividend yield?
EXOZYMES, INC. offers a dividend yield of 0.00%.
What is EXOZ's Deepscope Quality Score?
Deepscope rates EXOZ's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy EXOZ?
Deepscope's AI Timing Score for EXOZ is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does EXOZ belong to?
EXOZYMES, INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 9.34
Price
-0.01
(-0.11%)
Day Change
|
|
|---|
EXOZ, the overall quality is not good ( Quality = 23) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 9.34 |
| PBV / Sector |
52.49 / 4.63
|
| Earning Per Share | -1.13 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
0.04 M
GREAT
|
| Average 1W Daily Value |
0.05 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
8% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:24 |
| Symbol | EXOZ |
| Name | EXOZYMES, INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 8.48 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 80.21 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 750 Royal Oaks Drive, Monrovia, CA, United States, 91016
Phone: 626 415 1488
Website: https://www.exozymes.com
Sector: Healthcare >> Biotechnology
Description: eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
